Chronic Neutrophilic Leukemia (CNL) is a rare myeloproliferative disorder characterized by an increase in predominantly mature neutrophils in the blood. The diagnosis and understanding of CNL have evolved significantly with the advent of genetic testing, specifically targeting mutations in the CSF3R gene (exons 14 and 17) and the SETBP1 gene (exon 4). These genetic markers […]
